rs139158022
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_005422.4(TECTA):c.2827C>A(p.Leu943Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000199 in 1,613,714 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005422.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TECTA | NM_005422.4 | c.2827C>A | p.Leu943Met | missense_variant | 10/24 | ENST00000392793.6 | |
TBCEL-TECTA | NM_001378761.1 | c.3784C>A | p.Leu1262Met | missense_variant | 16/30 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TECTA | ENST00000392793.6 | c.2827C>A | p.Leu943Met | missense_variant | 10/24 | 5 | NM_005422.4 | P4 | |
TECTA | ENST00000264037.2 | c.2827C>A | p.Leu943Met | missense_variant | 9/23 | 1 | P4 | ||
TECTA | ENST00000642222.1 | c.2827C>A | p.Leu943Met | missense_variant | 10/24 | A1 | |||
TECTA | ENST00000645008.1 | c.136C>A | p.Leu46Met | missense_variant | 1/15 |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000191 AC: 48AN: 250840Hom.: 0 AF XY: 0.000214 AC XY: 29AN XY: 135592
GnomAD4 exome AF: 0.000192 AC: 281AN: 1461406Hom.: 0 Cov.: 34 AF XY: 0.000208 AC XY: 151AN XY: 727012
GnomAD4 genome AF: 0.000263 AC: 40AN: 152308Hom.: 0 Cov.: 32 AF XY: 0.000322 AC XY: 24AN XY: 74480
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 05, 2022 | Has been previously reported as benign (Sommen et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 27068579, 31554319, 9590290, 21520338) - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 12, 2022 | - - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 20, 2017 | The p.Leu943Met variant in TECTA has been previously reported in at least 2 Cauc asian individuals with hearing loss (Sommen 2016, LMM data). It has also been re ported in ClinVar (Variation ID 165358) as of uncertain significance. It has bee n identified in 31/126658 European chromosomes by the Genome Aggregation Databas e (gnomAD, http://gnomad.broadinstitute.org/; dbSNP rs139158022). Although this variant has been seen in the general population, its frequency is not high enoug h to rule out a pathogenic role. Computational prediction tools and conservation analyses suggest that the variant may not impact the protein, though this infor mation is not predictive enough to rule out pathogenicity. Of note, the leucine (Leu) at position 943 is conserved in mammals but several fish species carry a m ethionine (Met) at this position, raising the possibility this change may be tol erated. In summary, the clinical significance of the p.Leu943Met variant is unce rtain. - |
Autosomal recessive nonsyndromic hearing loss 21 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Autosomal dominant nonsyndromic hearing loss 12 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at